Clinical Trial Update: Vaccine Treatment for Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a vaccine treatment for advanced non-small cell lung cancer reported as completed in Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vaccine treatment (investigational, sponsor: NewLink Genetics Corporation)

Snippet

Sponsor: NewLink Genetics Corporation | Conditions: Non-small Cell Carcinoma, Adenocarcinoma of Lung | Phase 1, Phase 2 | Status: COMPLETED